奮達科技(002681.SZ):控股股東及實際控制人簽署《質押股票處置過户協議》
格隆匯6月23日丨奮達科技(002681.SZ)公佈,公司控股股東及實際控制人肖奮先生於2025年6月20日與深圳市高新投集團有限公司(簡稱“高新投”)簽署了《質押股票處置過户協議》,肖奮先生將其持有的39,376,820股公司股份,佔公司總股本的2.19%,通過非交易過户的方式,以5.84元/股的價格轉讓給高新投。肖奮先生曾因個人資金週轉需要,將其自身持有的部分公司股份質押於高新投,本次非交易過户金額全部用於償還股票質押融資本金。本次非交易過户不觸及要約收購,不構成關聯交易,不涉及公司控制權變更,對公司的資產、財務、業務等方面的獨立性不產生影響,對公司日常的經營管理不會產生影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.